Adjuvant Immunotherapy for Kidney Cancer — A New Strategy with New Challenges | NEJM
Surgery with curative intent constitutes the standard of care for patients with advanced renal-cell carcinoma, yet more than 50% of patients with high-risk features will have disease recurrence. Tw…